Log in

NASDAQ:SXTC - China SXT Pharmaceuticals Stock Price, Forecast & News

$0.86
-0.03 (-3.37 %)
(As of 02/21/2020 08:00 AM ET)
Today's Range
$0.81
Now: $0.86
$0.92
50-Day Range
$0.74
MA: $0.92
$1.15
52-Week Range
$0.65
Now: $0.86
$9.24
Volume1.29 million shs
Average Volume2.59 million shs
Market Capitalization$23.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives. China SXT Pharmaceuticals, Inc. was founded in 2005 and is based in Taizhou, China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
CIKN/A
Phone86-523-8629-8290

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.01 million
Cash Flow$0.07 per share
Book Value$0.49 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$23.85 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.


China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

Has China SXT Pharmaceuticals been receiving favorable news coverage?

News stories about SXTC stock have been trending somewhat positive this week, InfoTrie reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. China SXT Pharmaceuticals earned a news impact score of 1.3 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for China SXT Pharmaceuticals.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a decrease in short interest in January. As of January 31st, there was short interest totalling 118,500 shares, a decrease of 15.4% from the January 15th total of 140,000 shares. Based on an average daily volume of 647,400 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.9% of the company's stock are sold short. View China SXT Pharmaceuticals' Current Options Chain.

Who are some of China SXT Pharmaceuticals' key competitors?

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include AT&T (T), Verizon Communications (VZ), Gilead Sciences (GILD), HEXO (HEXO), Iconix Brand Group (ICON), Intel (INTC), JD.Com (JD), Ollie's Bargain Outlet (OLLI), Zynerba Pharmaceuticals (ZYNE) and AbbVie (ABBV).

Who are China SXT Pharmaceuticals' key executives?

China SXT Pharmaceuticals' management team includes the folowing people:
  • Mr. Feng Zhou, Chairman & CEO (Age 27)
  • Mr. Yao Shi, Chief Financial Officer (Age 38)
  • Dr. Jingzhen Deng, Chief Scientific Officer & COO (Age 59)
  • Mr. Jun Zheng, Exec. Director (Age 40)

Who are China SXT Pharmaceuticals' major shareholders?

China SXT Pharmaceuticals' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.64%).

Which major investors are buying China SXT Pharmaceuticals stock?

SXTC stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $0.86.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $23.85 million and generates $7.01 million in revenue each year. View Additional Information About China SXT Pharmaceuticals.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is http://www.sxtchina.com/.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]


MarketBeat Community Rating for China SXT Pharmaceuticals (NASDAQ SXTC)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  70 (Thanks for Voting!)
Underperform Votes:  93 (Thanks for Voting!)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about China SXT Pharmaceuticals and other stocks. Vote "Outperform" if you believe SXTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SXTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel